Pedro Loredo, MD
Surgery of the Hand · Grapevine, TXNPI 1417175209
Payments from drug & device makers
What this record shows
This record is dominated by education: $1,734 of the $2,724 with a category attached, or 63.7%. Pylant Medical accounts for 63.7% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2019 at $1,243 and has fallen 75.4% since, to $306 in 2025.
Across 48 payments — averaging $56.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pylant Medical$2K
- Amgen$256
- Smith+Nephew$184
- Orthofix Medical, Inc.$138
- Medtronic$87
- Electronic Waveform Lab, Inc.$59
- plus $266 from 10 others
What the payments were for
- Food & beverage$99036%
- Education$1,73464%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pylant Medical | 3 | $1,734 |
| Amgen(2 entities) | 11 | $256 |
| Smith+Nephew | 6 | $184 |
| Orthofix Medical, Inc. | 8 | $138 |
| Medtronic | 3 | $87 |
| Electronic Waveform Lab, Inc. | 6 | $59 |
| Axogen | 2 | $55 |
| Acumed LLC | 1 | $38 |
| Access Pro Medical, LLC | 1 | $33 |
| Biocircuit Technologies Inc | 1 | $26 |
| Hologic Sales And Service, LLC | 1 | $22 |
| Vertex | 1 | $22 |
| Polynovo North America LLC | 1 | $22 |
| Reprise Biomedical, Inc. | 1 | $20 |
| Advanced Oxygen Therapy Inc. | 1 | $17 |
| Endo Pharmaceuticals Inc. | 1 | $12 |
How this compares
$2,724 in reported general payments places this provider in the 60th percentile of 68 surgery of the hand providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 64 | $908 |
| Ondansetron OdtOndansetron | 21 | $245 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 25 | $209 |
| Gabapentin | 33 | $204 |
| Cyclobenzaprine Hcl | 20 | $127 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 29 | $95 |
| Methylprednisolone | 15 | $70 |
| Clindamycin Hcl | 13 | $63 |
Paid to pharmacies, not to this prescriber.
Other surgery of the hand in Grapevine
- Desirae McKeeLubbock$59K
- Stuart HilliardDenton$21K
- Harrison KayAustin$19K
- Suresh KoneruSan Antonio$17K
- Dustin RayDallas$15K
- Laurence WeiderDallas$13K
- Andrew ZhangDallas$11K
- James HovisArlington$11K
- James LinSpring$10K
- Michael JonesSan Antonio$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.